GlobalDeal

Ambergen

Biotechnology · Billerica, United States

ambergen.com

About Ambergen

Ambergen is a biotechnology company focused on developing innovative solutions for the treatment of neurodegenerative diseases. The company leverages advanced research methodologies and proprietary technologies to identify and validate therapeutic targets, aiming to improve patient outcomes in conditions such as Alzheimer's and Parkinson's disease. With a commitment to scientific excellence and collaboration, Ambergen partners with academic institutions and industry leaders to accelerate the development of its drug candidates. The company's research is driven by a team of experienced scientists and industry professionals dedicated to making a significant impact in the field of neuroscience.

Company facts

Industry
Biotechnology
Sub-industries
Pharmaceuticals, Neuroscience, Drug Development, Clinical Research, Biopharmaceuticals
Location
Billerica, United States
Employees
11–50
Revenue (USD)
1–5M
Founded
2018

Products and services

Open Ambergen in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in United States

All 17,138 Biotechnology companies in United States →